Top compounds associated with response to CHMP2B


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.03
mRNA LAQ824 GDSC1000 pan-cancer AAC -0.08 0.03
mRNA BX-912 GDSC1000 pan-cancer AAC -0.07 0.03
mRNA Panobinostat FIMM pan-cancer AAC 0.31 0.03
mRNA barasertib CTRPv2 pan-cancer AAC -0.076 0.03
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.079 0.03
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.072 0.03
mRNA CX-5461 GDSC1000 pan-cancer AAC -0.072 0.03
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.08 0.03
Download CSV